A phase I study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously daily for 5 consecutive days every 3 weeks in patients with advanced solid tumors (Q81460442)
Jump to navigation
Jump to search
scientific article published on 01 November 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously daily for 5 consecutive days every 3 weeks in patients with advanced solid tumors |
scientific article published on 01 November 2005 |
Statements
A phase I study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously daily for 5 consecutive days every 3 weeks in patients with advanced solid tumors (English)
Scot Ebbinghaus
Eric Rubin
Evan Hersh
Lee D Cranmer
Peter L Bonate
Robert J Fram
Antti Jekunen
Steve Weitman
Lisa A Hammond
1 November 2005